Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study
Published Online: 2021-07-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Aaron S Mansfield•Benjamin Besse•Byoung Chul Cho•Christina S Baik•Christopher D Turner•Corinne Clifford•Dae Ho Lee•Daniel S W Tan•Dong-Wan Kim•Elena Garralda•Gilberto Lopes•Giuseppe Curigliano•Hui Zhang•Jennifer Green•Justin F Gainor•Luis G Paz-Ares•Matthew H Taylor•Michael Palmer•Michael Thomas•Philippe A Cassier•Robert C Doebele•Shirish M Gadgeel•Stephen V Liu•Viola W Zhu•Vivek Subbiah
